Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-08-06

Clinical Trial Update: The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tranexamic acid for reducing blood loss during orthognathic surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Nick Emanuele | Conditions: Tranexamic Acid, Orthognathic Surgery | Phase 4 | Status: WITHDRAWN